Selective Repression of Truncated Proteins from Mutated mRNAs in Tumors
Author Information
Author(s): You Kwon Tae, Li Long Shan, Kim Nam-Gyun, Kang Hyun Ju, Koh Kwi Hye, Chwae Yong-Joon, Kim Kyoung Mi, Kim Yoon Ki, Park Sung Mi, Jang Sung Key, Kim Hoguen
Primary Institution: Yonsei University College of Medicine
Hypothesis
How do frameshift mutations in mRNAs affect protein expression in tumors?
Conclusion
Some mRNAs with premature termination codons can escape degradation but do not produce detectable truncated proteins due to translational repression.
Supporting Evidence
- Frameshift mutations in mRNAs lead to the formation of premature termination codons.
- Some PTC-containing mRNAs escape from the nonsense-mediated decay system.
- Truncated proteins from NMD-escape mRNAs were not detected in tumor cells.
- Transfection of wild-type genomic DNA resulted in normal protein expression.
- Transfection of mutant genomic DNA did not lead to truncated protein expression.
Takeaway
In some cancers, certain faulty mRNAs don't get broken down as they should, but they also don't make the proteins they are supposed to, which can be a problem for the cells.
Methodology
The study involved analyzing mRNA expression and protein production from mutated genes in colorectal cancer cell lines using techniques like Western blotting and RT-PCR.
Limitations
The study did not explore all possible factors influencing the expression of truncated proteins from PTC-containing mRNAs.
Participant Demographics
The study focused on colorectal cancer cell lines, including both MMR-deficient and MMR-proficient types.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website